A Message From Our Leadership
Our team brings together both clinical expertise and operational experience in the clinical research industry. This combination allows us to approach every study with a strong understanding of both patient care and the operational demands required for successful trial execution.
We believe that strong partnerships with Sponsors and CROs are essential to the success of clinical trials. Through transparency, responsiveness, and a commitment to excellence, we strive to be a trusted research partner for every study we support.
Leadership Team
Site Director/Co-Founder
Vivian Orazulike
Vivian serves as the Site Director and Co-Founder of Vigomed Clinical Trials, bringing over seven years of experience in the clinical research industry. With a background as a Clinical Research Associate (CRA), Vivian has extensive experience in clinical trial oversight, regulatory compliance, monitoring, and site operations.
Her industry experience provides a unique understanding of Sponsor and CRO expectations, enabling the site to operate with strong quality systems, efficient study execution, and proactive communication. Vivian is dedicated to building a research environment that prioritizes regulatory integrity, operational excellence, and successful collaboration with research partners.
Chief Technology Officer
Paul Orazulike
Paul Orazulike leads technology strategy and digital innovation at VIGOMED Clinical Trials. With extensive experience in enterprise technology, healthcare systems, automation, AI, and digital transformation, he oversees the development of secure and scalable technology solutions designed to enhance research operations, protect data integrity, and support efficient clinical trial execution.
Yemissi Sanni
Yemi serves as a budget and contract specialist, with 12 years of clinical research experience. Her experience has provided her with a strong foundation in study budgets, contract management, financial tracking, vendor coordination, and negotiation while maintaining a thorough understanding of clinical research requirements and regulatory expectations. She brings a comprehensive understanding of clinical trial operations, study management, and site level financial and contractual processes.